4//SEC Filing
ARGOS THERAPEUTICS INC 4
Accession 0000904454-17-000465
CIK 0001105533operating
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 8:17 PM ET
Size
7.8 KB
Accession
0000904454-17-000465
Insider Transaction Report
Form 4
Public Joint Stock Co Pharmstandard
10% Owner
Transactions
- Purchase
Convertible Secured Promissory Note
2017-06-21(indirect: See footnote)Exercise: $0.50From: 2017-06-21Exp: 2022-06-21→ Common Stock (12,000,000 underlying)
Pharmstandard International S.A.
10% Owner
Transactions
- Purchase
Convertible Secured Promissory Note
2017-06-21(indirect: See footnote)Exercise: $0.50From: 2017-06-21Exp: 2022-06-21→ Common Stock (12,000,000 underlying)
Footnotes (2)
- [F1]This Convertible Secured Promissory Note (the "Note") was issued by the Issuer in principal amount of $6,000,000 for a purchase price of $6,000,000, and bears interest at a rate of 9.5% per annum. The Reporting Person may at any time and from time to time convert all outstanding principal and any accrued but unpaid interest under the Note into shares of the Issuer's common stock at a price per share equal to $0.50, subject to adjustment as provided in the Note.
- [F2]Pharmstandard International S.A. is a wholly owned subsidiary of Pharmstandard JSC. As the parent entity, Pharmstandard JSC has voting power over the shares of the Issuer held by Pharmstandard International S.A.
Documents
Issuer
ARGOS THERAPEUTICS INC
CIK 0001105533
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001105533
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 8:17 PM ET
- Size
- 7.8 KB